How is the data centre industry evolving to meet the challenges of AI, sustainability, and energy security? In this episode of Built Environment Matters, Jaimie Johnston MBE speaks with Lincoln Wood, Director of Design at Edged.

What happens when drug discovery leaders, big pharma, regulators, AI solution providers, and venture capital sit in the same room? Bryden Wood's Accelerate roundtable on AI and pharmaceutical manufacturing surfaced a clear consensus: the hype is in the wrong places – and we are not ambitious enough.

As rack densities accelerate and IT infrastructure becomes more unpredictable, data centre design must shift from attempting to future-proof buildings to creating adaptable infrastructure that enables change. MEP Director Michael Hope-Jones explores why the traditional approach no longer works—and how a plant-first strategy offers a way forward.

Scale matters far more than most organisations realise. Professor John Dyson explores the often-overlooked concept of 'diseconomies of scale' - why bigger isn't always better - through an economic model that reveals how production unit size can dramatically impact financial returns in pharmaceutical portfolios.